본문 바로가기
HOME> 논문 > 논문 검색상세

논문 상세정보

Empirical Antifungal Therapy in Febrile Neutropenic Patients

Lee, Chang Seop   Oh, Myoung Don   Choe, Kang Won  
  • 초록

    Invasive fungal infection is an important cause of morbidity and mortality in granulocytopenic patients receiving cancer chemotherapy or undergoing bone marrow or stem-cell transplantation. The most common pathogens are Candida species and Aspergillus species, and other fungi are also encountered. Empirical antifungal therapy with conventional amphotericin B or liposomal amphotericin B has become the standard of care in reducing invasive fungal infections in patients with neutropenia and persistent fever. Amphotericin B is associated with significant dose-limiting nephrotoxicity and infusion-related reactions. Liposomal amphotericin B is equivalent to conventional amphotericin B as empirical antifungal therapy and significantly reduces proven invasive fungal infections, nephrotoxicity, and infusion-related reactions. The high acquisition cost of liposomal amphotericin B, however, has limited the use of this less toxic formulation of amphotericin B. The lipid formulations of amphotericin B and triazoles (fluconazole, itraconazole, voriconazole), were found to be a suitable alternative to amphotericin B preparations as empirical antifungal agents in patients with persistent fever and neutropenia. However, these agents may be associated with toxicity and adverse drug interactions and have a limited spectrum of activity, erratic bioavailability, unpredictable pharmacokinetics, and limited efficacy. Caspofungin is a relatively new class of antifungal agents that non-competitively inhibit the synthesis of fungal cell-wall 1, 3-beta-D-glucan. Caspofungin is a suitable alternative to liposomal amphotericin B as empirical therapy and offered the advantages of safety, improved survival, and improved response rates in patients with invasive fungal infections. However, caspofungin has a drug interactions with dexamethasone, cyclosporine, tacrolimus and is expensive. Numerous antifungal agents could represent potential alternatives to amphotericin B, a difficult drug to administer. The optimal empiric antifungal therapy remains a matter of controversy. Clinicians ultimately have to select the optimal antifungal agents after considering the cost as well as efficacy, toxicity of the drugs.


  • 주제어

    Neutropenia .   Persistent fever .   Antifungal agents.  

 활용도 분석

  • 상세보기

    amChart 영역
  • 원문보기

    amChart 영역

원문보기

무료다운로드
유료다운로드
  • 원문이 없습니다.

유료 다운로드의 경우 해당 사이트의 정책에 따라 신규 회원가입, 로그인, 유료 구매 등이 필요할 수 있습니다. 해당 사이트에서 발생하는 귀하의 모든 정보활동은 NDSL의 서비스 정책과 무관합니다.

원문복사신청을 하시면, 일부 해외 인쇄학술지의 경우 외국학술지지원센터(FRIC)에서
무료 원문복사 서비스를 제공합니다.

NDSL에서는 해당 원문을 복사서비스하고 있습니다. 위의 원문복사신청 또는 장바구니 담기를 통하여 원문복사서비스 이용이 가능합니다.

이 논문과 함께 출판된 논문 + 더보기